MedTrace Logo

Multidisciplinary Digital Therapeutics of Chronic Lower Back Pain Versus Usual Care

NCT05940025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-07-31

No results posted yet for this study

Summary

This randomized controlled pilot study will be evaluating an app, MORT-LBP app (ETH-02K), owned by EverEx, Inc., to examine safety and efficacy in individuals with chronic lower back pain.

Conditions

  • Chronic Low-back Pain

Interventions

DEVICE

MORT-LBP

The MORT-LBP, developed by EverEx, Inc., is designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioral therapy for patients with chronic lower back pain.

OTHER

treatment as usual (TAU)

In the control group, education and physiotherapy is delivered and self-exercise is recommended.

Sponsors & Collaborators

  • EverEx Inc.

    lead INDUSTRY

Principal Investigators

  • Sam Yeol Chang, M.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-16
Primary Completion
2024-04-04
Completion
2024-04-04

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940025 on ClinicalTrials.gov